DOONER, JAMES MD
Ophthalmology · NPI 1962474643 · AUSTIN, TX
DOONER, JAMES is a Ophthalmology in AUSTIN, TX, a member of 1 medical group, who billed 21 distinct codes to Medicare Part B in 2024.
Groups: AUSTIN RETINA ASSOCIATES PLLC (AUSTIN, TX)
Year: 2024 · 2023 · 2022 🔒 · 2021 🔒 · 2020 🔒
Provider overview · all codes · CY2024
All figures are disclosed (CMS suppresses fewer-than-11-beneficiary rows) Medicare Part B fee-for-service — a subset, never complete totals; volumes are personal to this NPI, not attributed to any group. Standing is a billed-volume position among specialty peers with disclosed billing (national percentile; a provider's true standing can only be higher, never lower), not a statement about care. See Methods & Sources.
Procedures billed to Medicare Part B (2024)
Medicare Part B FFS · CY2024 · as published by CMS| Code | Description | Services | Beneficiary-episodes | Avg charge | Avg Medicare payment |
|---|---|---|---|---|---|
| J2777 | Injection, faricimab-svoa, 0.1 mg | premium | premium | premium | premium |
| J2782 | Injection, avacincaptad pegol, 0.1 mg | premium | premium | premium | premium |
| 92134 | Imaging of retina | premium | premium | premium | premium |
| J0178 | Injection, aflibercept, 1 mg | premium | premium | premium | premium |
| 67028 | Injection of drug into eye | premium | premium | premium | premium |
| Q5128 | Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg | premium | premium | premium | premium |
| J2781 | Injection, pegcetacoplan, intravitreal, 1 mg | premium | premium | premium | premium |
| J0177 | Injection, aflibercept hd, 1 mg | premium | premium | premium | premium |
| 99213 | Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more | premium | premium | premium | premium |
| 92250 | Photography of the retina | premium | premium | premium | premium |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | premium | premium | premium | premium |
| 92014 | Established patient complete exam of visual system | premium | premium | premium | premium |
| 92004 | New patient complete exam of visual system | premium | premium | premium | premium |
| 99214 | Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more | premium | premium | premium | premium |
| 99204 | New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more | premium | premium | premium | premium |
| J9035 | Injection, bevacizumab, 10 mg | premium | premium | premium | premium |
| 92012 | Established patient problem focused exam of visual system | premium | premium | premium | premium |
| J3590 | Unclassified biologics | premium | premium | premium | premium |
| J3490 | Unclassified drugs | premium | premium | premium | premium |
| 76512 | 2d ultrasound scan of eye tissue and structures | premium | premium | premium | premium |
| 67042 | Removal of membrane of retina with removal of internal limiting membrane of retina | premium | premium | premium | premium |
These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.